Results 211 to 220 of about 2,828,087 (336)

The LysR-family transcriptional regulator VtlR coordinates carbon metabolism, oxidative and nitrosative stress resistance, and virulence in Brucella melitensis. [PDF]

Vet Res
Wang Y, Li M, Yang X, Yin Y, Liu J, Qu J, Bao Y, Qi J, Han X, Wang S, Tian M.   +10 more
europepmc   +1 more source

Homologous recombination mutant lethality differs between h− and h+ Schizosaccharomyces pombe strains due to mat1 heterochromatin [PDF]

Peter Kolesár, S. A. Paliavoi, Barbora Štefanovie, Jan Paleček   +3 more
openalex   +1 more source

Characterization of cis‐acting prgQ mutants: evidence for two distinct repression mechanisms by Qa RNA and PrgX protein in pheromone‐inducible enterococcal plasmid pCF10 [PDF]

, 2003
Taeok Bae, Briana Kozlowicz, Gary M. Dunny   +2 more
openalex   +1 more source

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

Nature, 2004
M. Arrasate, S. Mitra, E. Schweitzer, M. Segal, S. Finkbeiner   +4 more
semanticscholar   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Mutational landscape of gastrointestinal stromal tumors using next-generation sequencing of a 73-gene panel. [PDF]

World J Surg Oncol
Wang C, Cheng B, Yang S, Yin H, Xiong Y, Chen R, Wu Y, Wang C, Wang B, Gao Z, Ye Y.   +10 more
europepmc   +1 more source

Exploratory analysis of lamivudine legacy and clonal selection of HBs truncation mutants in HBV-related hepatocellular carcinoma [PDF]

Yu‐De Chu, Pei-Huan Ho, Chao‐Wei Hsu, Chih‐Yung Chiou, Ming‐Wei Lai, Chau‐Ting Yeh   +5 more
openalex   +1 more source

Different Proteolipid Protein Mutants Exhibit Unique Metabolic Defects [PDF]

, 2009
Maik Hüttemann, Zhan Zhang, Chadwick Mullins, Denise Bessert, Icksoo Lee, Klaus-Armin Nave, Sunita Appikatla, Robert P. Skoff   +7 more
openalex   +1 more source

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

Cancer Cell, 2014
P. Muller, K. Vousden
semanticscholar   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source